127 related articles for article (PubMed ID: 17146390)
21. Prospective phase II trial of concomitant boost radiotherapy for stage II nasopharyngeal carcinoma.
Lu JJ; Kong L; Shakespeare TP; Loh KS; Zhang Q; Tan KS; Lee KM
Oral Oncol; 2008 Jul; 44(7):703-9. PubMed ID: 18061528
[TBL] [Abstract][Full Text] [Related]
22. Comparison of technetium-99m methoxyisobutylisonitrile single photon emission computed tomography and computed tomography to detect recurrent or residual nasopharyngeal carcinomas after radiotherapy.
Shiau YC; Tsai SC; Ho YJ; Kao CH
Anticancer Res; 2001; 21(3C):2213-7. PubMed ID: 11501849
[TBL] [Abstract][Full Text] [Related]
23. [Application of 18F-FDG PET/CT scan in following-up of nasopharyngeal carcinoma after radiotherapy].
Yu DF; Zuo CT; Dai JZ; Dong MJ; Zhao J; Lin XT; Guan YH
Ai Zheng; 2004 Nov; 23(11 Suppl):1538-41. PubMed ID: 15566675
[TBL] [Abstract][Full Text] [Related]
24. Primary tumor volume calculation as a predictive factor of prognosis in nasopharyngeal carcinoma.
Lee CC; Chu ST; Ho HC; Lee CC; Hung SK
Acta Otolaryngol; 2008 Jan; 128(1):93-7. PubMed ID: 17851945
[TBL] [Abstract][Full Text] [Related]
25. Sp1 is over-expressed in nasopharyngeal cancer and is a poor prognostic indicator for patients receiving radiotherapy.
Wang J; Kang M; Qin YT; Wei ZX; Xiao JJ; Wang RS
Int J Clin Exp Pathol; 2015; 8(6):6936-43. PubMed ID: 26261581
[TBL] [Abstract][Full Text] [Related]
26. Long-term treatment outcome of recurrent nasopharyngeal carcinoma treated with salvage intensity modulated radiotherapy.
Hua YJ; Han F; Lu LX; Mai HQ; Guo X; Hong MH; Lu TX; Zhao C
Eur J Cancer; 2012 Dec; 48(18):3422-8. PubMed ID: 22835782
[TBL] [Abstract][Full Text] [Related]
27. Can post-RT neck dissection be omitted for patients with head-and-neck cancer who have a negative PET scan after definitive radiation therapy?
Rogers JW; Greven KM; McGuirt WF; Keyes JW; Williams DW; Watson NE; Geisinger K; Cappellari JO
Int J Radiat Oncol Biol Phys; 2004 Mar; 58(3):694-7. PubMed ID: 14967422
[TBL] [Abstract][Full Text] [Related]
28. Intensity-modulated radiation therapy without concurrent chemotherapy for stage IIb nasopharyngeal cancer.
Tham IW; Lin S; Pan J; Han L; Lu JJ; Wee J
Am J Clin Oncol; 2010 Jun; 33(3):294-9. PubMed ID: 20395788
[TBL] [Abstract][Full Text] [Related]
29. Using thallium-201 SPECT to detect recurrent or residual nasopharyngeal carcinoma after radiotherapy in patients with indeterminate CT findings.
Shiau YC; Liu FY; Huang WS; Yen RF; Kao CH
Head Neck; 2003 Aug; 25(8):645-8. PubMed ID: 12884347
[TBL] [Abstract][Full Text] [Related]
30. Epstein-Barr virus latent membrane protein 1 (EBV-LMP1) and tumor proliferation rate as predictive factors of nasopharyngeal cancer (NPC) radiation response.
Gondhowiardjo S
Gan To Kagaku Ryoho; 2000 May; 27 Suppl 2():323-31. PubMed ID: 10895175
[TBL] [Abstract][Full Text] [Related]
31. A Phase II study of docetaxel and carboplatin as neoadjuvant therapy for nasopharyngeal carcinoma with early T status and advanced N status.
Johnson FM; Garden A; Palmer JL; Kies M; Clayman G; Brumfield B; Khuri FR; Morrison W; Papadimitrakopoulou V; Diaz EM; Glisson BS
Cancer; 2004 Mar; 100(5):991-8. PubMed ID: 14983495
[TBL] [Abstract][Full Text] [Related]
32. Nasopharyngeal cancer in the Middle East: experience of the American University of Beirut Medical Center.
Geara FB; Nasr E; Tucker SL; Brihi E; Zaytoun G; Hadi U; Salem Z; El Saghir N; Issa P; Shamseddine A
Int J Radiat Oncol Biol Phys; 2005 Apr; 61(5):1408-15. PubMed ID: 15817344
[TBL] [Abstract][Full Text] [Related]
33. 18F-FDG-PET for evaluation of the response to concurrent chemoradiation therapy with intensity-modulated radiation technique for Stage T4 nasopharyngeal carcinoma.
Yen TC; Lin CY; Wang HM; Huang SF; Liao CT; Kang CJ; Ng SH; Chan SC; Fan KH; Chen IH; Lin WJ; Cheng AJ; Chang JT
Int J Radiat Oncol Biol Phys; 2006 Aug; 65(5):1307-14. PubMed ID: 16863922
[TBL] [Abstract][Full Text] [Related]
34. Radiographic assessment of the sinuses in patients treated for nasopharyngeal carcinoma.
Raviv J; Downing L; Le QT; Hwang P
Am J Rhinol; 2008; 22(1):64-7. PubMed ID: 17958946
[TBL] [Abstract][Full Text] [Related]
35. [Analysis of computed tomography-based distribution of metastatic cervical nodes in 218 cases of nasopharyngeal carcinoma].
Wang XS; Hu CS; Wu YR; Qiu XX; Feng Y
Ai Zheng; 2004 Sep; 23(9):1056-9. PubMed ID: 15363201
[TBL] [Abstract][Full Text] [Related]
36. The role of FDG PET in management of neck metastasis from head-and-neck cancer after definitive radiation treatment.
Yao M; Smith RB; Graham MM; Hoffman HT; Tan H; Funk GF; Graham SM; Chang K; Dornfeld KJ; Menda Y; Buatti JM
Int J Radiat Oncol Biol Phys; 2005 Nov; 63(4):991-9. PubMed ID: 16099601
[TBL] [Abstract][Full Text] [Related]
37. The use of MR imaging to detect residual versus recurrent nasopharyngeal carcinoma following treatment with radiation therapy.
Lin GW; Wang LX; Ji M; Qian HZ
Eur J Radiol; 2013 Dec; 82(12):2240-6. PubMed ID: 24103355
[TBL] [Abstract][Full Text] [Related]
38. Correlation of endoscopic and histologic findings before and after treatment for nasopharyngeal carcinoma.
Kwong DL; Nicholls J; Wei WI; Chua DT; Sham JS; Yuen PW; Cheng AC; Yau CC; Kwong PW; Choy DT
Head Neck; 2001 Jan; 23(1):34-41. PubMed ID: 11190856
[TBL] [Abstract][Full Text] [Related]
39. Concurrent chemoradiotherapy vs radiotherapy alone in stage II nasopharyngeal carcinoma: phase III randomized trial.
Chen QY; Wen YF; Guo L; Liu H; Huang PY; Mo HY; Li NW; Xiang YQ; Luo DH; Qiu F; Sun R; Deng MQ; Chen MY; Hua YJ; Guo X; Cao KJ; Hong MH; Qian CN; Mai HQ
J Natl Cancer Inst; 2011 Dec; 103(23):1761-70. PubMed ID: 22056739
[TBL] [Abstract][Full Text] [Related]
40. Nasopharyngeal carcinoma treated with precision-oriented radiation therapy techniques including intensity-modulated radiotherapy: preliminary results.
Liu WS; Su MC; Wu MF; Tseng HC; Kuo HC
Kaohsiung J Med Sci; 2004 Feb; 20(2):49-55. PubMed ID: 15481551
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
